August 16, 2025

Fibroblast activation protein inhibitor (FAPI)-negative huge renal cell carcinoma demonstrating an intriguing pattern on 99mTcTc-FAPI-46 scintigraphy.

View Full Paper

Ask AI

Bookmark

Authors

NRNasrin Raeisi ATAmin Saber Tanha SSSalman Soltani

Discussion

Member takes

Implication

Case presentation reveals an intriguing signature on [99mTc]Tc-FAPI-46 scintigraphy in renal cell carcinoma, suggesting diagnostic potential for imaging.

Key Points

Scintigraphy displayed photopenic areas and gallbladder accumulation in the tumor, indicating a unique pattern.
The 58-year-old male presented with flank pain and hematuria, leading to a diagnosis of clear cell renal cell carcinoma.
Comprehensive surgical resection involved the right kidney and surrounding organs, confirming the presence of ccRCC.
This case may highlight the emerging role of scintigraphy in identifying unique characteristics of renal tumors.

Cite This Study

Raeisi et al. (2025) studied this question.

synapsesocial.com/papers/68c23626b210217d64773bb3 https://doi.org/10.5603/nmr.106313

View Full Paper

Ask AI

Bookmark

Implication

Case presentation reveals an intriguing signature on [99mTc]Tc-FAPI-46 scintigraphy in renal cell carcinoma, suggesting diagnostic potential for imaging.

Fibroblast activation protein inhibitor (FAPI)-negative huge renal cell carcinoma demonstrating an intriguing pattern on 99mTcTc-FAPI-46 scintigraphy.

Discussion

Member takes

Implication

Key Points

Cite This Study

Fibroblast activation protein inhibitor (FAPI)-negative huge renal cell carcinoma demonstrating an intriguing pattern on 99mTcTc-FAPI-46 scintigraphy.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider